ImageneBio Free Cash Flow (FCF) History (IMA)

ImageneBio reported −$80.2M in free cash flow for fiscal 2023, a decrease of $4.6M from the previous fiscal year, with a free cash flow margin of −875.08%.

View full ImageneBio company overview

ImageneBio free cash flow by year

ImageneBio annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20232023-12-31−$80.2M−$4.6M−875.08%
20222022-12-31−$75.5M−$13.5M−483.67%
20212021-12-31−$62.0M−$23.4M−200.14%
20202020-12-31−$38.6M−419.75%

ImageneBio free cash flow growth trends

ImageneBio's latest reported quarter, Q4 2023, generated −$22.1M in free cash flow, a decrease of $4.2M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review ImageneBio filings at SEC.gov ↗